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Introduction: Patients with COPD experience exacerbations that may require hospitalization. 
Patients do not always feel supported upon discharge and frequently get readmitted. A Self-
management Program of Activity, Coping, and Education for COPD (SPACE for COPD), a 
brief self-management program, may help address this issue.
Objective: To investigate if SPACE for COPD employed upon hospital discharge would reduce 
readmission rates at 3 months, compared with usual care.
Methods: This is a prospective, single-blinded, two-center trial (ISRCTN84599369) with partici-
pants admitted for an exacerbation, randomized to usual care or SPACE for COPD. Measures, includ-
ing health-related quality of life and exercise capacity, were taken at baseline (hospital discharge) 
and at 3 months. The primary outcome measure was respiratory readmission at 3 months.
Results: Seventy-eight patients were recruited (n=39 to both groups). No differences were 
found in readmission rates or mortality at 3 months between the groups. Ten control patients 
were readmitted within 30 days compared to five patients in the intervention group (P.0.05). 
Both groups significantly improved their exercise tolerance and Chronic Respiratory Question-
naire (CRQ-SR) results, with between-group differences approaching statistical significance for 
CRQ-dyspnea and CRQ-emotion, in favor of the intervention. The “Ready for Home” survey 
revealed that patients receiving the intervention reported feeling better able to arrange their life 
to cope with COPD, knew when to seek help about feeling unwell, and more often took their 
medications as prescribed, compared to usual care (P,0.05).
Conclusion: SPACE for COPD did not reduce readmission rates at 3 months above that of 
usual care. However, encouraging results were seen in secondary outcomes for those receiv-
ing the intervention. Importantly, SPACE for COPD appears to be safe and may help prevent 
readmission with 30 days.
Keywords: COPD exacerbations, pulmonary rehabilitation, exercise, emphysema, self-
management
Introduction
Patients with COPD experience exacerbations, some of which require hospitalization,1 
which accounts for a significant proportion of the £810–930 million economic cost 
annually2 in the United Kingdom. Furthermore, exacerbations and admissions are 
associated with reduced physical functioning,3,4 which may contribute to the increased 
readmission risk.5 The 28-day readmission rates are ~33%,2 and hospitals are penalized 
financially if patients get readmitted within 30 days of discharge.6
A patient survey6 highlighted that individuals do not always feel able to cope at 
home postexacerbation. Additionally, patients report that they want more information 
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and advice on practical coping issues,6 highlighting the need 
for supportive interventions.
Pulmonary rehabilitation (PR) is one intervention that has 
increasingly been employed to address the reduced exercise 
capacity associated with exacerbations.7,8 PR consists of exer-
cise and education to promote health-enhancing behaviors.9 
Rehabilitation offered early after hospital discharge can 
reduce readmission rates and improve exercise capacity,7 but 
other studies have shown that it is difficult to recruit patients,8 
indicating that it may not be wholly acceptable during this 
period. Furthermore, no improvements in readmission rates 
or physical function were observed for an early intensive 
rehabilitation intervention over a longer, 12-month period,10 
highlighting the need for a different approach.
With finite health care resources, it is important to pre-
vent unnecessary hospital admissions. Given the detrimental 
physical and emotional effects of hospitalization, it is impor-
tant to devise an intervention to help reduce the associated 
impacts, while being safe and acceptable to patients.
Recent attention has been given to self-management 
interventions, from simple exacerbation management plans 
to comprehensive behavior-changing programs.11 However, 
there have been concerns with these types of interventions, 
particularly after an acute exacerbation, as recent studies have 
observed increased mortality rates within the intervention 
arms.10,12 Although reasons for this have not been established, 
it has been postulated that patients may have misplaced 
confidence in their self-management skills.
A Self-management Program of Activity, Coping, and 
Education13 for COPD (SPACE for COPD) improves clinical 
and health care utilization outcomes within a stable COPD 
population14 but has not been investigated as a stand-alone 
intervention within an acute setting. SPACE for COPD is a 
brief intervention containing practical advice, a home-based 
exercise program, and an exacerbation action plan that aims 
to support patients to manage their day-to-day activities and 
promote health-enhancing behaviors.
Our hypothesis was that a structured self-management 
strategy (SPACE for COPD) employed upon hospital 
discharge would reduce readmissions for patients with 
COPD, compared to usual care. We also investigated the 
effect of SPACE for COPD on exercise tolerance, psycho-
logical impact, health-related quality of life, and disease 
knowledge.
Methods
Design
A prospective, two-center, single-blinded randomized con-
trolled trial was conducted during January 2013–September 
2014. Participants provided written informed consent, and 
ethical approval was granted by National Research Ethics 
Service Committee West Midlands – Solihull, reference 
12/WM/0106, trial registration ISRCTN84599369.
Population
Participants were recruited from University Hospitals Coven-
try and Warwickshire and University Hospitals of Leicester 
NHS Trusts. Participants were included if they had an estab-
lished diagnosis of COPD and grade 2–5 dyspnea according 
to the Medical Research Council. Individuals were excluded 
if their reason for admission was not an acute exacerbation 
of COPD or if they were 1) unable to safely participate in 
unsupervised exercise (ie, due to psychiatric, locomotive, 
cardiac, or neurological impairments), 2) involved in other 
research, 3) unable to read English, 4) had previously 
received SPACE for COPD or completed PR within the 
previous 6 months, or 5) had four or more admissions in the 
previous 12 months.
randomization
Participants were randomized to receive usual care or SPACE 
for COPD via a web-based, concealed allocation program 
(www.sealedenvelope.com) using simple random permuted 
block 1:1 randomization by VJ-W. Randomization was per-
formed after the participants completed the baseline assess-
ment, with treatment allocation prior to hospital discharge.
Usual care
All participants received usual care during the study period. 
This consisted of a follow-up appointment with the commu-
nity COPD team or telephone follow-up after an inpatient 
review by a respiratory nurse specialist and an outpatient 
consultant review. Due to waiting times, participants did not 
receive PR during the study period.
sPaCe for COPD
SPACE for COPD has previously been described;13 briefly, 
it comprises written educational information and a home-
based exercise program (consisting of a daily walking-based 
aerobic program and thrice weekly resistance training using 
free weights of the upper and lower limbs). Participants 
were introduced to the manual and exercises by a trained 
physiotherapist (VJ-W) in a one-to-one session lasting 
30–45 minutes, using motivational interviewing techniques 
to facilitate behavior change, goal setting, and problem 
solving. Participants were advised how to progress and that 
the manual could be valuable for the future to reinforce any 
life-long lifestyle changes. Participants received structured 
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phone calls within 72 hours and at 2 weeks, 4 weeks, 6 weeks, 
8 weeks, and 10 weeks from hospital discharge with the aim 
of reinforcing skills, helping identify and manage exacerba-
tions, promoting an active lifestyle, and providing encour-
agement, while tailoring to patient needs. If participants 
get readmitted during the 3-month follow-up period, they 
continued the intervention as planned.
Outcome measures
The primary prespecified outcome measure was respiratory-
related hospital readmission at 3 months. Secondary out-
comes were the Chronic Respiratory Questionnaire – self 
reported (CRQ-SR),15 Hospital Anxiety and Depression 
Score,16 Bristol COPD Knowledge Questionnaire,17 Incre-
mental Shuttle Walk Test (ISWT),18 Endurance Shuttle 
Walking Test (ESWT),19 Pulmonary Rehabilitation Adapted 
Index of Self-Efficacy,20 and the “Ready for Home” survey.6 
All outcomes were measured at baseline (during admission 
but as close to discharge as possible) and 3 months after 
randomization, by a clinician blinded to treatment allocation. 
Mortality and readmission data were collected from hospital 
and primary care databases.
sample size
Based on the primary outcome measure of readmission 
at 3 months, 36 participants were required in each arm to 
detect a fall in readmissions comparable to Seymour et al.21 
Calculations were based on 5% significance (alpha 0.05), 
80% power, and two-tailed test using the SAS system.
statistical analysis
Data were tested for normality and appropriate parametric 
or nonparametric tests used. For binary variables (including 
primary outcome measure), Fisher’s exact test was used to 
compare differences between the two groups. Odds ratios 
were calculated for 30-day readmissions. Independent t-tests 
or Kruskal–Wallis tests were used to compare between-
group differences. Paired t-tests or Wilcoxon signed rank 
tests were used to compare within-group changes. Statistical 
significance was accepted if P,0.05. Analysis was conducted 
on an intention-to-treat basis. Number (and percentages) of 
those achieving the known minimal clinically important dif-
ferences of 0.5 for CRQ-SR,22 -1.5 for Hospital Anxiety and 
Depression Score,23 47.5 m for ISWT,24 and 186 seconds for 
ESWT25 was calculated.
Protocol changes
Ethical approval was granted to reduce the time given to 
participants to consider study participation from 24 hours 
to whenever they felt they fully understood. This was to 
allow the inclusion of patients with a short hospital stay (ie, 
those with mild COPD exacerbations) or those discharged 
over a weekend.
Results
The consort diagram (Figure 1) describes the trial recruit-
ment. Eighty-five patients consented, of whom 78 were 
randomized (39 to each arm) and included in the intention-
to-treat analysis with 36 in usual care and 35 in SPACE for 
COPD available with follow-up data.
Table 1 shows the baseline characteristics. No significant 
differences existed in baseline measures between groups 
(P.0.05) or outcome measures between sites (P.0.05). 
Twenty-two patients used home oxygen (ten used both 
long-term oxygen therapy and ambulatory, eight used solely 
long-term oxygen therapy, two ambulatory, and two pal-
liative oxygen) at a mean (standard deviation) flow rate of 
1.52 (0.57) L.
Primary outcome measure
Twenty-five patients (32.05%) were readmitted for respiratory 
reasons during the 3-month follow-up period: 13 receiving usual 
care and 12 receiving the intervention (33.33% vs 30.77%, 
P=0.808). Figure 2 shows the Kaplan–Meier curves.
health care utilization
Readmission data were nonnormally distributed. Thirty-
one patients (14 controls and 17 receiving the intervention, 
P=0.488) were readmitted for any reason during the 3-month 
period, with 44 admissions (21 in usual care and 23 in inter-
vention, P=0.726). Respiratory reasons accounted for 79.55% 
of these readmissions (19 in usual care and 16 in SPACE for 
COPD, P=0.674).
Table 2 shows the hospital length of stay for those who 
got readmitted. Median (interquartile range) days to first 
respiratory readmission was 14 (4–39) for usual care com-
pared to 47 (4.5–55.5) for the intervention (P=0.341).
Ten usual care patients were readmitted within 30 days 
for respiratory reasons compared to five patients receiving the 
intervention (25.64% vs 12.82%, P=0.151), odds ratio (95% 
confidence interval) 0.426 (0.131–1.391), P.0.05.
All participants were offered PR after the study period. 
Fourteen patients expressed an interest (seven in each 
group).
Mortality
Within the 3-month study period, three usual care patients 
died (all due to respiratory reasons, median 65 days to 
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death), whereas no patients receiving SPACE for COPD 
died, P=0.077. Data censored on September 30, 2014 (mean 
339 days to censoring), revealed that seven usual care 
patients and three patients receiving SPACE for COPD had 
died, P=0.176.
serious adverse events
Only hospitalizations and mortality were reported as serious 
adverse events (SAEs). No other SAEs were found.
exercise and questionnaire data
ISWT and ESWT were nonnormally distributed. Table 3 
and Figure 3 show within- and between-group differences 
for quality of life, disease knowledge, exercise tolerance, 
and self-efficacy. Within-group changes (P,0.05) were 
seen for both groups for all CRQ-SR domains except 
emotion for usual care (P=0.216). Between-group differ-
ences approached statistical significance for CRQ-dyspnea 
(P=0.062) and -emotion (P=0.077) domains, in favor of 
the intervention. Both groups significantly increased their 
exercise tolerance (P,0.05). Disease-specific knowledge 
increased from baseline for those who received SPACE for 
COPD (P,0.05) but not for usual care. Table 4 shows that 
more patients who received the intervention achieved the 
minimal clinically important difference for CRQ-dyspnea 
(P=0.039).
At 3 months, Table 5 shows how people felt upon their 
(initial) discharge from hospital from the Ready for Home 
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Figure 1 COnsOrT diagram.
Abbreviations: sPaCe, self-management Program of activity, Coping, and education; Pr, pulmonary rehabilitation; MrC, Medical research Council; UhCW, University 
hospitals Coventry and Warwickshire nhs Trust; Uhl, University hospitals of leicester nhs Trust.
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Discussion
The supported self-management program, SPACE for COPD, 
delivered at the time of an acute exacerbation, did not reduce 
respiratory-related hospital readmissions at 3 months. How-
ever, benefits in quality of care and potential improvements in 
health-related quality of life, delaying time to first readmis-
sion, and reducing hospital length of stay were observed for 
those receiving the intervention. We did not find an increased 
mortality rate, and thus, SPACE for COPD appears a safe 
intervention in this population.
Within-group changes were observed for most outcomes 
for both groups. This gives further support that patients, after 
an acute exacerbation requiring hospitalization, experience 
a period of natural recovery.10 There were encouraging 
trends for improved outcomes in those receiving SPACE for 
COPD compared to those receiving usual care, especially for 
CRQ-SR (with dyspnea and emotion scores improving by 
more than double for those receiving the intervention com-
pared to usual care) and time to first readmission, although 
many did not reach statistical significance. This is likely 
due to the relatively small number of participants, so these 
secondary outcomes are likely to be underpowered.
Although not statistically significant, there were 
more admissions within the 30-day postdischarge period 
for respiratory reasons (attracting financial penalties of 
~£2,00026 each) in the group receiving usual care compared 
to the self-management group. Therefore, SPACE for 
COPD may be a feasible, brief intervention implement-
able immediately upon hospital discharge to help reduce 
this financial consequence and provide some benefits in 
quality of life and emotional support. Patients could then 
attend more intensive interventions when stable and natural 
recovery has plateaued, such as outpatient PR, which has 
established health and economic benefits.27 However, we 
found that only 14 participants expressed an interest in 
attending PR. Furthermore, 164 patients declined to take 
Table 1 Baseline characteristics of the study population
Characteristic Usual care SPACE for COPD
sex, male:female 13:26 15:24
age, years 68.33 (7.73) 67.64 (8.54)
FeV1, l 0.95 (0.36) 0.96 (0.45)
FeV1, % 42.45 (11.73) 40.47 (15.71)
FeV1/FVC ratio, % 42.77 (10.54) 47.09 (13.95)
Body mass index 23.75 (5.61) 25.49 (5.97)
smoking status (n)
Current:ex:never 18:21:0 14:24:1
smoking pack years 48.33 (29.02) 52.39 (34.32)
Disease duration, years 6.90 (5.99) 7.89 (7.43)
Marital status (n)
Married:partner:divorced: 
widowed:single
12:2:11:12:2 18:4:8:7:2
lives (n)
alone:with partner:with family 19:12:8 14:17:8
gOlD stage (n)
I:II:III:IV 0:10:12:12 0:10:16:11
Medical research Council 
dyspnea grade
4 (3–5) 4 (3–5)
2:3:4:5 (n) 6:5:13:15 4:7:12:16
exercise history (n)
Current:previous:never 6:22:11 6:20:13
Note: Values are mean (sD) or median (interquartile range).
Abbreviations: sD, standard deviation; sPaCe, self-management Program of 
activity, Coping, and education; FeV1, forced expiratory volume in 1 second; FVC, 
forced vital capacity; gOlD, global Initiative for chronic Obstructive lung Disease.
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Figure 2 Kaplan–Meier plots showing risk of respiratory readmission by randomization.
Abbreviation: sPaCe, self-management Program of activity, Coping, and education.
survey. More patients following SPACE for COPD felt con-
fident that medications could help and were reassured that 
good support was available at home compared to usual care 
(P,0.05). Table 6 shows that more patients in the SPACE 
for COPD arm felt that they were better able to arrange their 
life to cope with COPD, knew when to seek help about feel-
ing unwell, and more often took their medications on time 
as prescribed, compared to usual care (all P,0.05).
Table 2 hospital length of stay (for readmission)
Usual care SPACE for 
COPD
Between-group 
difference
Intention-to-treat
all-cause 16.5 (3.8–39.8) 9.0 (1.0–30.0) P=0.218
respiratory 15.0 (3.5–32.0) 12.0 (9.0–33.8) P=0.341
nonrespiratory 27.0 (7.5–33.8) 1.0 (1.0–3.0) P=0.067
Per protocol
all-cause 13.0 (3.3–25.5) 9.0 (1.0–27.8) P=0.381
respiratory 11.0 (3.0–21.0) 11.0 (8.8–37.5) P=0.597
nonrespiratory 27.0 (7.5–33.8) 1.0 (0.8–2.0) P=0.044
Note: Values are median (interquartile range) days.
Abbreviation: sPaCe, self-management Program of activity, Coping, and education.
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Figure 3 Change in Chronic respiratory Questionnaire – self reported data from baseline to 3 months.
Note: *P,0.05, **P,0.01, within group difference.
Abbreviations: NS, not significant; SPACE, Self management Programme of Activity Coping and Education; CRQ, Chronic Respiratory Questionnaire.
Table 3 Baseline and change in secondary outcome measures at 3 months
Usual care SPACE for COPD Between-group 
differenceBaseline Change Baseline Change
CrQ-dyspnea 2.22 (0.95) 0.45 (1.17)* 2.36 (0.99) 1.05 (1.26)** P=0.062
CrQ-fatigue 2.40 (0.97) 0.62 (1.21)** 2.23 (1.08) 0.99 (1.22)** P=0.245
CrQ-emotion 3.41 (1.29) 0.37 (1.60) 3.12 (0.99) 1.09 (1.51)** P=0.077
CrQ-mastery 3.24 (1.36) 0.89 (1.51)** 2.81 (1.11) 1.41 (1.48)** P=0.181
IsWT (m) 60 (10–167.50) 30 (0–95)** 60 (30–150) 45 (0–70)** P=0.769
esWT (seconds) 50 (0–171) 155 (21–618.50)** 110 (8–196.50) 178.5 (-3.75 to 443.50)** P=0.951
haDs-anxiety 7.79 (3.84) 0.28 (3.48) 9.62 (4.33) -0.27 (3.45) P=0.563
haDs-depression 7.18 (3.18) 0.76 (4.30) 6.97 (4.18) 0.54 (3.29) P=0.833
PraIse 39.08 (9.40) 2.34 (8.73) 40.15 (7.73) 0.54 (9.48) P=0.465
BCKQ 31.71 (9.21) 2.10 (7.19) 33.90 (8.38) 3.92 (7.14)* P=0.364
Notes: Mean (sD) or median (IQr) are reported as appropriate. *P,0.05 within-group difference, **P,0.01 within-group difference.
Abbreviations: sD, standard deviation; IQr, interquartile range; sPaCe, self-management Program of activity, Coping, and education; CrQ, Chronic respiratory 
Questionnaire; IsWT, Incremental shuttle Walk Test; esWT, endurance shuttle Walk Test; haDs, hospital anxiety and Depression scale; PraIse, Pulmonary rehabilitation 
Adapted Index of Self-Efficacy; BCKQ, Bristol COPD Knowledge Questionnaire.
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Table 4 number (%) of participants who achieved the MCID
Usual 
care
SPACE 
for COPD
Between-group 
difference
CrQ-dyspnea 11 (36.67%) 19 (63.33%) P=0.039*
CrQ-fatigue 17 (56.67%) 23 (76.67%) P=0.104
CrQ-emotion 17 (56.67%) 19 (63.33%) P=0.605
CrQ-mastery 22 (73.33%) 22 (73.33%) P=1.000
IsWT 9 (42.86%) 11 (50%) P=0.648
esWT 8 (47.06%) 10 (50%) P=0.863
haDs-anxiety 5 (17.24%) 9 (34.62%) P=0.151
haDs-depression 10 (34.48%) 8 (30.77%) P=0.775
Note: *P,0.05.
Abbreviations: MCID, minimal clinically important difference; CrQ, Chronic 
respiratory Questionnaire; IsWT, Incremental shuttle Walk Test; esWT, endurance 
shuttle Walk Test; haDs, hospital anxiety and Depression scale; sPaCe, self 
management Programme of activity Coping and education.
part in this study. Reasons for this varied mainly from none 
being given to having done similar previous research or 
PR before, preferring to wait for PR, feeling “too old” or 
not well enough.
Previous studies10,12 have found an increased mortality rate 
in self-management interventions, which, although not fully 
understood, has caused safety concerns in delivering these 
types of interventions. We did not show an increased mor-
tality rate (nor other SAEs) for those who received SPACE 
for COPD, compared to usual care; therefore, this particular 
intervention appears to be safe, at least in the short term. 
Previous authors10 reasoned that their observed increased 
mortality rates could be due to either chance, failure to inter-
vene or alterations in health behavior, which delay patients 
seeking medical advice. In our study, patients who received 
the self-management program reported that they better knew 
when to seek medical advice when feeling unwell, suggest-
ing that they would not delay seeking advice. Furthermore, 
patients receiving SPACE for COPD also reported more 
often taking their medications on time as prescribed. These 
are positive behavior change perceptions; however, this did 
not translate into preventing readmissions.
Limitations to this study include recruitment constraints. 
Due to available resources, there was not complete coverage 
to recruit during peak admission periods on both sites. In 
addition, some inpatient stays were so brief that being able to 
perform all research procedures within a busy, acute clinical 
setting was difficult.
This study, along with others, has shown that it can be 
difficult to prevent hospital readmission in a sick population. 
To take on board all information during a relatively short 
introduction to our self-management program, while patients 
are unwell and may have impaired cognition,28 may have 
contributed to the limited effectiveness of this intervention. 
Furthermore, all participants received specialist, usual care 
follow-up, and so their care could already be optimum. How-
ever, SPACE for COPD may help increase patient’s self-man-
agement ability and confidence in the short term as displayed 
by the delay in time to readmission. It may be unreasonable to 
expect a reduction in readmission rates and arguably should 
not be seen as a negative outcome for the trial; it may be more 
realistic to anticipate a change in other aspects of successful 
disease management, for example, health-related quality of 
life. Analyses of qualitative interviews and health economic 
data may provide further insight into this and participants’ 
compliance and adherence to the intervention.
Conclusion
In conclusion, we found that SPACE for COPD, delivered 
upon hospital discharge and supported postdischarge, 
did not reduce readmission rate at 3 months compared to 
usual care alone. However, we did find that this supported 
self-management intervention provided some potential 
benefits in health-related quality of life and delaying time 
Table 5 how people feel upon discharge from hospital following treatment for their COPD (% per group)
Very Fairly Neither 
yes or no
Not 
really
Not at 
all
Don’t 
know
Between-group 
differences
UC SM UC SM UC SM UC SM UC SM UC SM
ready (well enough) to leave hospital 39 43 39 33 7 0 11 20 4 0 0 3 P=0.976
reassured about being able to cope at home 36 53 29 23 7 7 21 13 4 3 0 0 P=0.230
Informed about your COPD and reasons for admission 29 47 21 27 11 0 18 13 7 3 7 3 P=0.086
Confident about how/when to take medications 68 70 18 20 4 0 11 3 0 0 0 0 P=0.444
Confident that COPD medications could help 46 67 36 30 4 3 14 0 0 0 0 0 P=0.049*
reassured that good support was available at home 46 67 18 23 14 3 7 0 7 3 7 0 P=0.022*
Positive about the future 18 27 29 43 18 10 17 10 10 0 0 0 P=0.156
Notes: not all participants completed each question; therefore, not all scores total 100%. *P,0.05.
Abbreviations: UC, usual care; sM, self-management (self management Programme of activity, Coping and education (sPaCe)).
International Journal of COPD 2016:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1168
Johnson-Warrington et al
Table 6 effect of (baseline) hospitalization on how people felt they changed and consequently managed their COPD (%)
Increased/better/
more often
No change Reduced/worsened/
less often
Between-group 
difference
UC SPACE 
for COPD
UC SPACE 
for COPD
UC SPACE for 
COPD
Your level of exercise and general activities 14 37 57 43 29 20 P=0.097
Your ability to arrange your life to cope with COPD 11 50 79 40 11 10 P=0.012*
Taking your medications on time as prescribed 17 57 71 43 4 0 P=0.017*
Knowing when to seek help about feeling unwell 43 73 57 23 0 3 P=0.038*
Your efforts to give up/avoid smoking 36 40 46 37 7 3 P=0.438
Your participation in discussion forums/groups 0 13 75 67 7 7 P=0.161
The use of available community support services 4 30 82 60 11 3 P=0.058
Notes: not all participants completed each question; therefore, not all scores total 100%. *P,0.05.
Abbreviations: UC, usual care; sPaCe, self-management Program of activity, Coping, and education.
to first readmission, which appears safe, as additional mor-
tality was not incurred, in contrast to findings from other 
recent studies.
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